Billy Lee names strong Limerick side to take on Wicklow in crucial Division 3 clash Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Advertisement Limerick Ladies National Football League opener to be streamed live A big thank you to his supporters from Cllr Cian Prendiville.by Alan [email protected] up for the weekly Limerick Post newsletter Sign Up A big thank you to his supporters from Cllr Cian Prendiville.ANTI Austerity Alliance councillor Cian Prendiville who was just 278 votes short of unseating Education Minister Jan O’Sullivan in the General Election warned this week that his party are here to stay.Cllr Prendiville, who received a total of 6,774 votes, was back out on the streets of Limerick City this Monday to thank all those who voted for the AAA.“We are here to stay, and this election is just the beginning of a political revolution,” he insisted.“The political elite is in free fall. Their time is passing, and our political revolution has only just begun.”Cllr Prendiville also appealed to all those who voted for him and the AAA, to now take the next step and get involved in building this new movement for workers and young people by joining up.“I see a lot of talk about how Fianna Fáil gained votes in Limerick, and obviously they did. However, far bigger than any swing to Fianna Fail was the huge swing to AAA. We can add to this the 2,500 people who gave their first preference to O’Dea, largely because they felt they owed him a favour but then voted for us as a statement of their desire for real change,” he claimed.“Don’t believe the hype, this election is still Fianna Fáil’s second worst election in the history of the State. In fact, they have even gone down across the country compared to the percentage vote they got in the local elections two years ago. The real story of this election is the collapse of the political elite and the huge breakthrough made by the AAA in building a real alternative,” he concluded. Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” Previous articleHermitage Green launch ‘Save Your Soul’ this Saturday at HMV LimerickNext articleLimerick woman rescued from bridge over River Shannon Alan Jacqueshttp://www.limerickpost.ie RELATED ARTICLESMORE FROM AUTHOR WhatsApp Twitter Print NewsLocal NewsOnly the beginning for Limerick political revolutionary CianBy Alan Jacques – March 3, 2016 760 Limerick’s National Camogie League double header to be streamed live Facebook Linkedin WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads TAGSAnti Austerity AllianceCllr Cian Prendivillegeneral election 2016limerick Email
Read Full Story Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on Jan. 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died. With no FDA–approved treatments available to date, the anti-malarial drug, hydroxychloroquine, has emerged as a potential therapy for the pneumonia associated with COVID-19, with or without the antibiotic azithromycin.In a brief report published this week in JAMA Cardiology, a team of pharmacists and clinicians at Beth Israel Deaconess Medical Center (BIDMC), part of Beth Israel Lahey Health, found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at increased risk of electrical changes to the heart and cardiac arrhythmias. The combination of hydroxychloroquine with azithromycin was linked to even greater changes compared to hydroxychloroquine alone.“While hydroxychloroquine and azithromycin are generally well-tolerated medications, increased usage in the context of COVID-19 will likely increase the frequency of adverse drug events (ADEs),” said co-first author Nicholas J. Mercuro, a pharmacy specialist in infectious diseases at BIDMC. “This is especially concerning given that that patients with underlying cardiac co-morbidities appear to be disproportionately affected by COVID-19 and that the virus itself may damage the heart.”Hydroxychloroquine and azithromycin each can cause an electrical disturbance in the heart known as a QTc prolongation, indicated by a longer space between specific peaks on an electrocardiogram. QTc prolongation denotes that the heart muscle is taking milliseconds longer than normal to recharge between beats. The delay can cause cardiac arrhythmias, which in turn increases the likelihood of cardiac arrest, stroke or death.In this single-center, retrospective, observational study, Mercuro and colleagues evaluated 90 adults with COVID-19 who were hospitalized at BIDMC between March 1 and April 7, and received at least one day of hydroxychloroquine. More than half of these patients also had high blood pressure, and more than 30 percent had diabetes.Seven patients (19 percent) who received hydroxychloroquine alone developed prolonged QTc of 500 milliseconds or more, and three patients had a change in QTc of 60 milliseconds or more. Of the 53 patients who also received azithromycin, 21 percent had prolonged QTc of 500 milliseconds or more, and 13 percent experienced a change in QTc of 60 milliseconds or more.“In our study, patients who were hospitalized and receiving hydroxychloroquine for COVID-19 frequently experienced QTc prolongation and adverse drug events,” said co-first author Christina F. Yen, MD, of BIDMC’s Department of Medicine. “One participant taking the drug combination experienced a potentially lethal tachycardia called torsades de pointes, which to our knowledge has yet to be reported elsewhere in the peer-reviewed COVID-19 literature.”In 2003, preliminary data suggested hydroxychloroquine may be effective against SARS-CoV-1, a fatal but hard-to-transmit respiratory virus related to the coronavirus that causes COVID-19. More recently, a small study of patients with COVID-19 appeared to benefit from the anti-malarial drug. Subsequent research, however, has failed to confirm either finding. In light oftheir data, Gold and colleagues urge caution and careful consideration before administering hydroxychloroquine as treatment for COVID-19.“If considering the use of hydroxychloroquine, particularly combined with azithromycin, clinicians should carefully weigh the risks and benefits, and closely monitor QTc — particularly considering patients’ co-morbidities and concomitant medication use,” said senior author Howard S. Gold, MD, an infectious disease specialist at BIDMC and an assistant professor of medicine at Harvard Medical School. “Based on our current knowledge, hydroxychloroquine for the treatment of COVID-19 should probably be limited to clinical trials.”Co-authors included BIDMC’s Christopher M. McCoy, David J. Shim , Peter J. Zimetbaum, and Timothy R. Maher.
continue reading » The Federal Open Market Committee (FOMC), the Federal Reserve’s monetary policy-setting arm, begins a two-day meeting today, which is not expected to end with a rate hike.The committee last raised the federal funds target rate to the current range of 2.25 to 2.5 percent at the end of its December meeting, the fourth rate hike of 2018.Following its March meeting, the committee indicated that the current range is expected to remain the same in 2019 and that only one rate hike will be in made in the next two years. NAFCU Chief Economist and Vice President of Research Curt Long, has previously predicted that the likelihood of an interest rate hike in 2019 is minimal. In addition, most economists agree that the Fed will hold at the current rate through 2020, according to a new Bloomberg survey. The Federal Reserve ShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr